Scabisan Plus (Permethrin)
Active Ingredient: Permethrin
Dosage: 120 ml
Route of Administration: Local
Dosage Form: Emulsion
Quantity per package: 1 unit
Availability: Out of stock
Scabisan Plus is a synthetic pyrethroid that fights Sarcoptes scabiei. The emulsion contains permethrin that acts as a neurotoxin that depolarizes the nerve cell membrane in the parasite.
Scabisan Plus is currently out of stock but you can search for a similar medication here.
Treatment of scabiasis (scabies).
Dosage and administration
Adults and children over 2 months: Apply the emulsion with a gentle massage on the skin from the neck to the soles of the feet. Scabies rarely parasites the scalp of the head in the adult. However, in children and geriatric patients, there may be an infestation in the root of hair, neck, temples and forehead implantation. Usually, 30 g is enough for the treatment of a normal adult. The emulsion should be removed by bathing after 8 to 14 hours during the bath. Children and the elderly should be treated including temples, forehead and scalp. A single application is usually sufficient for the elimination of the infestation. It is recommended to apply the treatment to the whole family, to avoid recurrent infection among its members.
Scabisan Plus is contraindicated in patients with hypersensitivity to the active substance or to the components of the formula. The use of this product is not recommended in children under 2 months of age because the safety and efficacy of permethrin have not been established in this group of patients. Do not apply this product to patients with a history of seizures or burns, skin wounds and skin rash.
In some cases, the emulsion can cause pruritus, erythema and other irritating manifestations, such as burning. They are mild and transient.
Overdosing of Scabisan Plus causes dryness, cracking of the skin and other more severe manifestations. In case of skin reaction, stop treatment and apply softening cream. If you have a cutaneous inflammatory reaction, use oral antihistamines or topical corticosteroids.
In cases of ingestion, signs of gastrointestinal intolerance (epigastric pain, nausea, vomiting and diarrhea) may occur. Treatment: induced vomiting, gastric lavage, supportive measures to counteract symptoms.
Drug interactions have not been described to date.